Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Nishiyama · SciRah

Researcher profile · Semantic Scholar

H. Nishiyama

Share profile

H. Nishiyama — researcher profile on SciRah

h-index: 43
Works: 526
Citations: 9,560

Most-cited papers

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
T. Powles, Z. Assaf, N. Davarpanah, R. Banchereau +23 more
2021Nature612 citations
Semantic Scholar
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
A. Balar, A. Kamat, G. Kulkarni, E. Uchio +14 more
2021The Lancet Oncology461 citations Open access
Semantic Scholar
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
J. Bellmunt, M. Hussain, J. Gschwend, P. Albers +22 more
2021The Lancet Oncology352 citations Open access
Semantic Scholar
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
T. Powles, Z. Assaf, V. Degaonkar, P. Grivas +15 more
2023European Urology159 citations
Semantic Scholar
Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision
H. Matsumoto, K. Shiraishi, H. Azuma, K. Inoue +19 more
2020International journal of urology117 citations Open access
Semantic Scholar
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
Takashi Kobayashi, Katsuhiro Ito, T. Kojima, Minoru Kato +20 more
2020Cancer Science70 citations Open access
Semantic Scholar
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303.
M. Galsky, C. Hoimes, A. Necchi, N. Shore +9 more
2021Future Oncology66 citations Open access
Semantic Scholar
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
Takashi Kobayashi, Katsuhiro Ito, T. Kojima, S. Maruyama +20 more
2021Cancer Immunology and Immunotherapy40 citations
Semantic Scholar
KEYNOTE-B15/EV-304: Randomized phase 3 study of perioperative enfortumab vedotin plus pembrolizumab versus chemotherapy in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC).
C. Hoimes, J. Bedke, Y. Loriot, H. Nishiyama +4 more
202139 citations
Semantic Scholar
Cystoscopic Imaging for Bladder Cancer Detection Based on Stepwise Organic Transfer Learning with a Pretrained Convolutional Neural Network
A. Ikeda, H. Nosato, Y. Kochi, H. Negoro +4 more
2020Journal of endourology36 citations
Semantic Scholar
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Mizuki Kobayashi, S. Narita, Y. Matsui, Souhei Kanda +27 more
2021BJU International30 citations
Semantic Scholar
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer
K. Mizuno, T. Sumiyoshi, Takatsugu Okegawa, N. Terada +33 more
2021Clinical Cancer Research30 citations Open access
Semantic Scholar
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
Ken Tanaka, S. Kandori, Shotaro Sakka, Satoshi Nitta +13 more
2021Oncology Report29 citations Open access
Semantic Scholar
Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
M. Miyake, Kota Iida, N. Nishimura, Tatsuki Miyamoto +21 more
2021BMC Cancer28 citations Open access
Semantic Scholar
Pembrolizumab (pembro) for the treatment of patients with Bacillus Calmette-Guérin (BCG) unresponsive, high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Over two years follow-up of KEYNOTE-057.
A. Balar, A. Kamat, G. Kulkarni, E. Uchio +13 more
202026 citations
Semantic Scholar
1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy
T. Powles, Z. Assaf, N. Davarpanah, M. Hussain +16 more
202024 citations Open access
Semantic Scholar
PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer.
Y. Nagumo, Syuya Kandori, Kozaburo Tanuma, Satoshi Nitta +8 more
2021Cancer Letters23 citations Open access
Semantic Scholar
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
Katsuhiro Ito, Takashi Kobayashi, T. Kojima, Kensuke Hikami +22 more
2021Cancer Medicine23 citations Open access
Semantic Scholar
Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
Minoru Kato, Takashi Kobayashi, Y. Matsui, Katsuhiro Ito +25 more
2021International journal of urology21 citations
Semantic Scholar
Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)
K. Kobayashi, H. Matsuyama, T. Kawai, A. Ikeda +16 more
2022International journal of urology20 citations Open access
Semantic Scholar
The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells
Masanobu Shiga, J. Miyazaki, Kozaburo Tanuma, Y. Nagumo +15 more
2021Cancer Immunology and Immunotherapy20 citations Open access
Semantic Scholar
Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
M. Yonamine, K. Wasano, Y. Aita, T. Sugasawa +17 more
2021Cancers19 citations Open access
Semantic Scholar
The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
K. Kobayashi, Shingo Yamamoto, Satoshi Takahashi, Kiyohito Ishikawa +57 more
2020Journal of Infection and Chemotherapy18 citations
Semantic Scholar
Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) versus chemotherapy in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-B15/EV-304.
C. Hoimes, Y. Loriot, J. Bedke, H. Nishiyama +3 more
2023Journal of Clinical Oncology17 citations
Semantic Scholar
Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial.
A. Necchi, M. Roumiguié, A. A. Esen, T. Lebret +16 more
2023Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Health-related quality of life in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study using the EORTC QLQ-TC26.
S. Yamashita, K. Kakimoto, M. Uemura, T. Kishida +15 more
2021Urology15 citations
Semantic Scholar
Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms
H. Negoro, T. Iizumi, Yutaro Mori, Y. Matsumoto +5 more
2020Journal of Clinical Medicine15 citations Open access
Semantic Scholar
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors
T. Kawahara, K. Kawai, T. Kojima, Y. Nagumo +15 more
2022International journal of urology14 citations Open access
Semantic Scholar
Impact of Early Exposure to Simulation Program on Undergraduate Medical Students’ Interest in Urology
T. Kimura, Kosuke Kojo, Masanobu Shiga, I. Chihara +5 more
2021Journal of Medical Education and Curricular Development14 citations Open access
Semantic Scholar
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer
N. Terada, T. Mizowaki, Toshihiro Saito, A. Yokomizo +26 more
2020BJUI Compass14 citations Open access
Semantic Scholar
The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up
Kosuke Okada, Takahisa Watahiki, K. Horie, Takako Takayama +7 more
2021Medicine13 citations Open access
Semantic Scholar
Management of prostate cancer in older patients.
S. Narita, S. Hatakeyama, S. Sakamoto, Takuma Kato +5 more
2022Japanese Journal of Clinical Oncology12 citations Open access
Semantic Scholar
Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
M. Miyake, N. Nishimura, Kota Iida, Tomomi Fujii +19 more
2021Cancers12 citations Open access
Semantic Scholar
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
N. Nishiyama, Takashi Kobayashi, S. Narita, Y. Hidaka +24 more
2021Journal of Geriatric Oncology12 citations
Semantic Scholar
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer
M. Shiota, N. Terada, H. Kitamura, T. Kojima +34 more
2021Cancer Science12 citations Open access
Semantic Scholar
Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study
Katsuhiro Ito, Y. Kita, A. Yokomizo, J. Miki +12 more
2022Cancer Medicine11 citations Open access
Semantic Scholar
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
M. S. van der Heijden, T. Powles, D. Petrylak, R. de Wit +21 more
2022Nature Communications11 citations Open access
Semantic Scholar
Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre‐enfortumab vedotin era
Y. Kita, Katsuhiro Ito, Tomoyasu Sano, K. Hashimoto +16 more
2022International journal of urology10 citations
Semantic Scholar
Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case Study
Haruna Nonaka, S. Kandori, Satoshi Nitta, Masanobu Shiga +13 more
2021Frontiers in Oncology10 citations Open access
Semantic Scholar
Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
K. Numakura, Y. Muto, S. Naito, S. Hatakeyama +14 more
2021Cancer Medicine10 citations Open access
Semantic Scholar
Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital‐Based Cancer Registry data in Japan
Masanobu Shiga, Y. Nagumo, I. Chihara, Satoshi Nitta +7 more
2021International journal of urology10 citations
Semantic Scholar
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
S. Naito, T. Kato, K. Numakura, S. Hatakeyama +16 more
2021International Journal of Clinical Oncology10 citations
Semantic Scholar
Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
H. Kitamura, S. Hinotsu, T. Tsukamoto, T. Shibata +6 more
2020Japanese Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Phase 2 study of the efficacy and safety of erdafitinib in patients (pts) with bacillus Calmette-Guérin (BCG)-unresponsive, high-risk non–muscle-invasive bladder cancer (HR-NMIBC) with FGFR3/2 alterations (alt) in THOR-2: Cohort 2 interim analysis results.
J. Catto, B. Tran, V. Master, M. Rouprêt +15 more
2023Journal of Clinical Oncology9 citations
Semantic Scholar
Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma
Y. Nagumo, Syuya Kandori, T. Kojima, Kazuki Hamada +6 more
2022Cancers9 citations Open access
Semantic Scholar
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
R. Kato, S. Naito, K. Numakura, S. Hatakeyama +13 more
2022International Journal of Clinical Oncology9 citations Open access
Semantic Scholar
External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study.
K. Okita, S. Hatakeyama, S. Naito, K. Numakura +13 more
2021Urologic oncology9 citations Open access
Semantic Scholar
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
Kota Iida, M. Miyake, Kaoru Murakami, M. Komiyama +16 more
2021International Journal of Clinical Oncology9 citations
Semantic Scholar
Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.
Kosuke Kojo, K. Kawai, T. Kawahara, T. Kimura +7 more
2020Japanese Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden
Y. Nagumo, Mizuki Onozawa, T. Kojima, N. Terada +16 more
2022International journal of urology8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Kojima×28
Invite
T. Kojima — researcher profile on SciRah
H. Kitamura×16
Invite
H. Kitamura — researcher profile on SciRah
Takashi Kobayashi×13
Invite
Takashi Kobayashi — researcher profile on SciRah
Y. Nagumo×10
Invite
Y. Nagumo — researcher profile on SciRah

×9

Invite

Katsuhiro Ito — researcher profile on SciRah

Masanobu Shiga×9

Invite

Masanobu Shiga — researcher profile on SciRah

Invite

T. Habuchi — researcher profile on SciRah

S. Hatakeyama×8

Invite

S. Hatakeyama — researcher profile on SciRah

Invite

H. Negoro — researcher profile on SciRah

Invite

P. Grivas — researcher profile on SciRah

H. Matsumoto×7

Invite

H. Matsumoto — researcher profile on SciRah

Invite

C. Ohyama — researcher profile on SciRah